Skip to main content
ABT
NYSE Life Sciences

Abbott Partners with ALZpath for Alzheimer's Blood Test, Targeting 80% of IVD Market

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$90.72
Mkt Cap
$157.686B
52W Low
$81.97
52W High
$139.06
52W Position info
11% above low
Off High info
35% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ABT is trading near its 52-week low of $81.97 (11% above the low).

Summary

Abbott Laboratories has partnered with ALZpath to develop a blood-based Alzheimer's diagnostic test, aiming to offer a less invasive alternative to current methods. This licensing deal is significant as ALZpath's CEO states that with Abbott, their antibody will be used by partners covering roughly 80% of the in-vitro diagnostic market. This represents a material expansion of Abbott's diagnostics portfolio into a high-demand area. U.S. regulatory approvals for some partners are expected in the second half of the year.

At the time of this announcement, ABT was trading at $90.72 on NYSE in the Life Sciences sector, with a market capitalization of approximately $157.7B. The 52-week trading range was $81.97 to $139.06. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ABT - Latest Insights

ABT
Nov 04, 2026, 4:13 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $115.48
Real-time Price: $113.57 info
Change: -$1.91 (-2%) info
Market Cap: $196.572B info
ABT
Oct 21, 2026, 8:53 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $98.21
Real-time Price: $113.57 info
Change: +$15.36 (+16%) info
Market Cap: $196.572B info
ABT
Oct 21, 2026, 7:36 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $99.52
Real-time Price: $113.57 info
Change: +$14.05 (+14%) info
Market Cap: $196.572B info
ABT
Oct 21, 2026, 7:32 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $100.55
Real-time Price: $113.57 info
Change: +$13.02 (+13%) info
Market Cap: $196.572B info
ABT
Oct 21, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $100.52
Real-time Price: $113.57 info
Change: +$13.05 (+13%) info
Market Cap: $196.572B info